Potent and selective inhibitor of class I histone deacetylases (HDACs) (IC50
values are 36, 47, 510 and 14,000 nM for HDAC1, HDAC2, HDAC4 and HDAC6 respectively). Exhibits cytotoxicity against various human tumor cell lines; also exhibits antitumor activity against human tumor xenografts.
Soluble to 10 mM in DMSO
Store at -20°C
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Effects of FK228, a novel histone deacetylase inhibitor, on tumor growth and expression of p21 and c-myc genes in vivo.
Sasakawa et al.
Cancer Lett., 2003;195:161
Involvement of extracellular signal-regulated kinase activation in human osteosarcoma cell resistance to the histone deacetylase inhibitor FK228 [(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-bis(propan-2-y
Matsubara et al.
FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases.
Furumai et al.
Cancer Res., 2002;62:4916
The citations listed below are publications that use Tocris products. Selected citations for FK 228 include:
Showing Results 1 - 1 of 1